Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant
File version
Version of Record (VoR)
Author(s)
Collier, D
Ritchie, A
Assennato, SM
Hosmillo, M
Goel, N
Meng, B
Chatterjee, K
Mendoza, V
Temperton, N
Kiss, L
James, LC
Ciazynska, KA
Martin, J
et al.
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
Abstract
© 2020 The Author(s) Mlcochova et al. report that combined rapid nucleic acid amplification testing (NAAT) and finger prick blood antibody tests can substantially improve the diagnosis of COVID-19 as compared to NAAT alone and is able to detect the SARS-CoV-2 Spike D614G variant that dominates the pandemic.
Journal Title
Cell Reports Medicine
Conference Title
Book Title
Edition
Volume
1
Issue
6
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2020 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Item Access Status
Note
Access the data
Related item(s)
Subject
Analytical biochemistry
Pharmacology and pharmaceutical sciences
Biomedical and clinical sciences
Persistent link to this record
Citation
Mlcochova, P; Collier, D; Ritchie, A; Assennato, SM; Hosmillo, M; Goel, N; Meng, B; Chatterjee, K; Mendoza, V; Temperton, N; Kiss, L; James, LC; Ciazynska, KA; Martin, J; et al., Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant, Cell Reports Medicine, 2020, 1 (6), pp. 100099